Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Crinetics Pharmaceuticals Inc
(NQ:
CRNX
)
48.00
-1.42 (-2.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Crinetics Pharmaceuticals Inc
< Previous
1
2
3
Next >
CRNX Stock Earnings: Crinetics Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
May 09, 2024
CRNX stock results show that Crinetics Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Endocrine Disease-Focused Crinetics Pharmaceuticals Stock Soars On Tuesday - Here's Why
March 19, 2024
Crinetics Pharmaceuticals unveils PATHFNDR-2 Phase 3 results for paltusotine in acromegaly treatment. Statistically significant efficacy & safety, with plans for FDA submission in 2024.
Via
Benzinga
Exposures
Product Safety
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 19, 2024
Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results.
Via
Benzinga
The Analyst Verdict: Crinetics Pharmaceuticals In The Eyes Of 6 Experts
February 29, 2024
Via
Benzinga
Crinetics Pharmaceuticals: Q4 Earnings Insights
February 28, 2024
Via
Benzinga
Crinetics Pharmaceuticals Earnings Preview
February 27, 2024
Via
Benzinga
Analyst Scoreboard: 4 Ratings For Crinetics Pharmaceuticals
December 19, 2023
Via
Benzinga
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
March 19, 2024
U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Biotech Stock Crinetics Jets Higher On Second Phase 3 Trial Win
March 19, 2024
Biotech stock Crinetics Pharmaceuticals rocketed early Tuesday after solid trial results for its oral growth hormone treatment.
Via
Investor's Business Daily
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
March 01, 2024
U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
8 Analysts Have This to Say About Crinetics Pharmaceuticals
November 20, 2023
Via
Benzinga
11 Analysts Have This to Say About Crinetics Pharmaceuticals
October 24, 2023
Via
Benzinga
Why Crinetics Pharmaceuticals Stock Soared This Week
September 15, 2023
A positive late-stage trial readout fueled a major rally in the drugmaker's shares.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
January 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 28, 2023
Via
Benzinga
Endocrine Diseases-Focused Crinetics Pharmaceuticals Highlights Favorable Initial Findings From Mid-Stage Study
December 19, 2023
Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) released initial findings from its ongoing open-label Phase 2 carcinoid syndrome (CS) study of paltusotine, an oral, once-daily investigational compound...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 09, 2023
Via
Benzinga
7 Speculative Stocks Set to Explode Higher
October 03, 2023
On the search for high-risk, high-reward opportunities? Consider taking a look at these seven speculative stocks.
Via
InvestorPlace
Top 4 Health Care Stocks That Should Keep You Up At Night
September 21, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Up 83% in 5 Days, Is Crinetics Pharmaceuticals a Buy?
September 19, 2023
Despite good results in phase 3 trials, there are barriers to its drug candidate's success.
Via
The Motley Fool
What's Going On With Crinetics Pharmaceuticals Stock?
September 12, 2023
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) shares are trading higher Tuesday.
Via
Benzinga
Nasdaq Rises Over 1%; Hostess Brands Shares Spike Higher
September 11, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on Monday. The Dow traded up 0.29% to 34,676.52 while the NASDAQ rose 1.16% to 13,920.60. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
September 11, 2023
Via
Benzinga
Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
September 11, 2023
Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study...
Via
Benzinga
Why Shares of Crinetics Pharmaceuticals Are Jumping Monday
September 11, 2023
The biotech company reported positive phase 3 trial results.
Via
The Motley Fool
Gold Edges Higher; Virco Manufacturing Shares Surge After Q2 Results
September 11, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 80 points on Monday. The Dow traded up 0.40% to 34,715.88 while the NASDAQ rose 0.58% to 13,841.50. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crinetics Pharma's Investigational Candidate Shows Promise In Rare Type Of Hormonal Disorder
September 11, 2023
On Sunday, Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) said its Phase 3 PATHFNDR-1 study evaluating paltusotine met the primary and secondary
Via
Benzinga
Crinetics Pharmaceuticals Just Scored A Much-Needed Win And Soared 71%
September 11, 2023
The company is working on a treatment for a growth hormone disorder.
Via
Investor's Business Daily
US Stocks Open Higher; Dow Jumps 150 Points
September 11, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Monday. Following the market opening Monday, the Dow traded up 0.46% to 34,736.26 while the NASDAQ rose 0.94% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Nuwellis (NUWE) Stock Down Today?
September 11, 2023
Nuwellis (NUWE) stock is taking a beating on Monday despite a lack of news or increased trading activity for the medical device company.
Via
InvestorPlace
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.